Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.

Yao Y, Harrison KA, Al-Hassani M, Murphy RC, Rezania S, Konger RL, Travers JB.

J Biol Chem. 2012 Mar 16;287(12):9311-21. doi: 10.1074/jbc.M111.332395.

2.

Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species.

Yao Y, Wolverton JE, Zhang Q, Marathe GK, Al-Hassani M, Konger RL, Travers JB.

J Immunol. 2009 Mar 1;182(5):2842-8. doi: 10.4049/jimmunol.0802689.

3.

Ultraviolet B radiation of human skin generates platelet-activating factor receptor agonists.

Travers JB, Berry D, Yao Y, Yi Q, Konger RL, Travers JB.

Photochem Photobiol. 2010 Jul-Aug;86(4):949-54. doi: 10.1111/j.1751-1097.2010.00743.x.

4.

The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists.

Sahu RP, Turner MJ, DaSilva SC, Rashid BM, Ocana JA, Perkins SM, Konger RL, Touloukian CE, Kaplan MH, Travers JB.

Carcinogenesis. 2012 Jul;33(7):1360-7. doi: 10.1093/carcin/bgs152.

5.

Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.

Sahu RP, Petrache I, Van Demark MJ, Rashid BM, Ocana JA, Tang Y, Yi Q, Turner MJ, Konger RL, Travers JB.

J Immunol. 2013 Mar 1;190(5):2447-54. doi: 10.4049/jimmunol.1202699.

6.

Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor.

Travers JB, Edenberg HJ, Zhang Q, Al-Hassani M, Yi Q, Baskaran S, Konger RL.

J Invest Dermatol. 2008 Feb;128(2):455-60.

7.

Epidermal platelet-activating factor receptor activation and ultraviolet B radiation result in synergistic tumor necrosis factor-alpha production.

Wolverton JE, Al-Hassani M, Yao Y, Zhang Q, Travers JB.

Photochem Photobiol. 2010 Jan-Feb;86(1):231-5. doi: 10.1111/j.1751-1097.2009.00618.x.

8.

Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line.

Barber LA, Spandau DF, Rathman SC, Murphy RC, Johnson CA, Kelley SW, Hurwitz SA, Travers JB.

J Biol Chem. 1998 Jul 24;273(30):18891-7.

9.

Platelet-activating factor does not mediate UVB-induced local immune suppression.

Sahu RP, Yao Y, Konger RL, Travers JB.

Photochem Photobiol. 2012 Mar-Apr;88(2):490-3. doi: 10.1111/j.1751-1097.2011.01071.x.

10.

Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage.

Marathe GK, Johnson C, Billings SD, Southall MD, Pei Y, Spandau D, Murphy RC, Zimmerman GA, McIntyre TM, Travers JB.

J Biol Chem. 2005 Oct 21;280(42):35448-57.

12.

UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency.

Tanaka K, Kamiuchi S, Ren Y, Yonemasu R, Ichikawa M, Murai H, Yoshino M, Takeuchi S, Saijo M, Nakatsu Y, Miyauchi-Hashimoto H, Horio T.

Mutat Res. 2001 Jun 2;477(1-2):31-40.

PMID:
11376684
13.

Studies of in vivo mutations in rpsL transgene in UVB-irradiated epidermis of XPA-deficient mice.

Murai H, Takeuchi S, Nakatsu Y, Ichikawa M, Yoshino M, Gondo Y, Katsuki M, Tanaka K.

Mutat Res. 2000 May 30;450(1-2):181-92.

PMID:
10838142
14.

Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.

Sahu RP, Ocana JA, Harrison KA, Ferracini M, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK, Perkins SM, Speicher PJ, Tyler DS, Konger RL, Travers JB.

Cancer Res. 2014 Dec 1;74(23):7069-78. doi: 10.1158/0008-5472.CAN-14-2043.

15.

Decreased UV sensitivity, mismatch repair activity and abnormal cell cycle checkpoints in skin cancer cell lines derived from UVB-irradiated XPA-deficient mice.

Ichikawa M, Nakane H, Marra G, Corti C, Jiricny J, Fitch M, Ford JM, Ikejima M, Shimada T, Yoshino M, Takeuchi S, Nakatsu Y, Tanaka K.

Mutat Res. 2000 May 31;459(4):285-98.

PMID:
10844242
16.
17.

Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair.

Sreevidya CS, Fukunaga A, Khaskhely NM, Masaki T, Ono R, Nishigori C, Ullrich SE.

J Invest Dermatol. 2010 May;130(5):1428-37. doi: 10.1038/jid.2009.329.

18.

Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice.

Kuwamoto K, Miyauchi-Hashimoto H, Tanaka K, Eguchi N, Inui T, Urade Y, Horio T.

J Invest Dermatol. 2000 Feb;114(2):241-6.

19.

Ultraviolet radiation-induced impairment of tumor rejection is enhanced in xeroderma pigmentosum a gene-deficient mice.

Miyauchi-Hashimoto H, Sugihara A, Tanaka K, Horio T.

J Invest Dermatol. 2005 Jun;124(6):1313-7.

20.

Involvement of platelet-activating factor in ultraviolet B-induced hyperalgesia.

Zhang Q, Sitzman LA, Al-Hassani M, Cai S, Pollok KE, Travers JB, Hingtgen CM.

J Invest Dermatol. 2009 Jan;129(1):167-74. doi: 10.1038/jid.2008.181.

Supplemental Content

Support Center